Venous Thromboembolism

Direct oral anticoagulants vs warfarin for bleeding risk in VTE

Direct oral anticoagulants vs warfarin for bleeding risk in VTE

By

Compared with warfarin, treatment with DOACs was not associated with an increased risk of major bleeding or all-cause mortality within the first 90 days.

No evidence that the influenza vaccine causes VTE

No evidence that the influenza vaccine causes VTE

In the 1 to 10 days after flu vaccine administration, there was no increased risk for VTE.

Non-vitamin K oral anticoagulants with other medications increase bleeding risk in A-Fib

Non-vitamin K oral anticoagulants with other medications increase bleeding risk in A-Fib

The researchers found that concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk of major bleeding compared with the use of NOACs alone.

Increased cancer risk found in rheumatoid arthritis patients with VTE

Increased cancer risk found in rheumatoid arthritis patients with VTE

VTE and cancer are the result of inflammation and immunological dysfunctions associated with RA.

Venous thromboembolism risk strongly linked to height in men and women

Venous thromboembolism risk strongly linked to height in men and women

By

Researchers found a strong association between VTE and height using sibling pair analysis.

About 5% of patients with unprovoked VTE develop occult cancer

About 5% of patients with unprovoked VTE develop occult cancer

Researchers observed a linear increase in cancer prevalence with age, with a 7-fold higher prevalence in patients older than 50 years of age.

Comparing anticoagulants to prevent venous thromboembolism after hip and knee arthroplasty

Comparing anticoagulants to prevent venous thromboembolism after hip and knee arthroplasty

By

Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee arthroplasty.

Effects of the obesity paradox: VTE risk in atrial fibrillation

Effects of the obesity paradox: VTE risk in atrial fibrillation

By

Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.

Rivaroxaban decreased VTE rate in high-risk orthopedic joint surgery patients

Rivaroxaban decreased VTE rate in high-risk orthopedic joint surgery patients

By

Researchers developed a protocol to demonstrate the efficacy of rivaroxaban in lowering the risk of venous thromboembolism among orthopedic joint surgery patients.

Restarting anticoagulation may be cost-effective in some VTE cases

Restarting anticoagulation may be cost-effective in some VTE cases

The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.

Warfarin dosing in HIV patients with deep venous thrombosis

Warfarin dosing in HIV patients with deep venous thrombosis

Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.

Surgical pulmonary embolectomy for thrombus distribution is feasible, effective

Surgical pulmonary embolectomy for thrombus distribution is feasible, effective

By

Surgical pulmonary embolectomy for peripheral distribution of thrombus demonstrated positive outcomes in patients with either CPE or PPE.

Short-term oral corticosteroid use associated with increased risk for sepsis, venous thromboembolism

Short-term oral corticosteroid use associated with increased risk for sepsis, venous thromboembolism

By

Approximately 1 in 5 American adults use corticosteroids in the short term, which is associated with an increased risk for sepsis, venous thromboembolism, and fracture.

Testosterone treatment may increase risk of venous thromboembolism

Testosterone treatment may increase risk of venous thromboembolism

By

Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.

Warfarin may be linked to reduced thromboembolism in nonvalvular atrial fibrillation

Warfarin may be linked to reduced thromboembolism in nonvalvular atrial fibrillation

The reduction in thromboembolism was attenuated after accounting for competing death events.

In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detection

In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detection

By

Unprovoked venous thromboembolism has been associated with the presence of occult malignancies.

Sign Up for Free e-newsletters